Home

Jed Latkin

CIK 1554593 · CEO, COO & CFO · last filed 2024-03-19

Jed Latkin is a CEO, COO & CFO who has filed 15 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for PRPH, was dated Mar 19, 2024. Across all open-market trades the lifetime net is +$34.8K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

15

Lifetime Open-Market Net

$34.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRPH Director — $0.11 — $0 1 2024-03-19
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted CEO, COO & CFO 118,597 $0.00 $12 $34.8K 14 2021-02-17

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-03-19 PRPH Grant (A) — $0 EDGAR
2021-02-17 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) — $0 EDGAR
2020-08-18 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) +50,000 $50 EDGAR
2020-06-04 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) +33,997 $89.1K EDGAR
2020-02-20 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +5,000 $5.4K EDGAR
2020-02-07 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) — $0 EDGAR
2019-06-07 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +1,000 $1.3K EDGAR
2019-05-17 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +2,500 $3.6K EDGAR
2019-05-15 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +5,400 $9.7K EDGAR
2019-02-11 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.